NanoString Technologies, Inc. launched a novel solution for detecting genetic copy number variations (CNVs) associated with disease susceptibility, drug response, and cancer progression.
GE Healthcare announced that Dr. Michael Freeley from the Institute of Molecular Medicine, Trinity College Dublin is winner of the first GE Healthcare HCA Award.
ISPE announced that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner of the 2010 Facility of the Year Awards (FOYA) program.
Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI.
The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients.
According to a new report released today by Citeline Drug Intelligence, the 240th meeting of the American Chemical Society disappointed expectations with a lack of new drug targets being announced at the event.
Substandard and counterfeit versions of thirteen key antimalarial medicines were uncovered in multiple locations across Ghana by the Medicines Quality Monitoring surveillance program.
Doctors have sharply cut some financial ties to drug companies, thanks to increased scrutiny about relationships that critics say improperly influence medical treatment, a survey suggests.
Resarchers studying a drug known for its pain-relieving ability appears to improve the health of retinas damaged by diabetes.
Using a novel, real-time imaging system, scientists have tracked a group of near-infrared fluorescent nanoparticles from the airspaces of the lungs, into the body and out again.
Micromet, Inc. announced plans to advance the Company’s BiTE antibody MT112/BAY 2010112 into formal preclinical development in collaboration with Bayer Schering Pharma AG, Germany.
Amgen announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa (zoledronic acid) in delaying or preventing skeletal-related events (SREs) in breast cancer patients with bone metastases.
EMD Millipore announced the introduction of new multiplex assay kits that can provide greater insight into the biochemical changes associated with Alzheimer's disease, Parkinson's disease, and other neurological disorders.
Grace Davison Discovery Sciences announced the launch of new flash cartridges in Amino and Diol phases for use with the Reveleris Flash Chromatography System.
Expression Analysis and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.